For the 84% of SCS patients who will need at least 1 MRI within 5 years of implant, BIOTRONIK Neuro has them covered. RESONANCE powered by BioARC TM uses a proprietary pattern of …

First FDA-approved SCS system that allows 1.5T & 3T full body scans in normal operating mode with no exclusion zones. Embrace One: unparalleled proactive care* enabled by automatic, …

BIOTRONIK Neuro’s Prospera spinal cord stimulation (SCS) system treats patients suffering from chronic pain, helping them embrace life again. The system uniquely features: …

With its new spinal cord stimulation (SCS) system Prospera™, BIOTRONIK’s neuromodulation team aims to support chronic pain patients and help them embrace life again.

BIOTRONIK Neuro is a division of BIOTRONIK, a leading medical device company that has been improving the lives of patients with heart and blood vessel diseases for decades. At …

2023年10月5日 · Biotronik today announced positive results from a clinical trial for its Neuro Prospera spinal cord stimulation (SCS) system. The BENEFIT-02 trial evaluates the …

The company launched a new business segment called Biotronik Neuro, based in Lake Oswego, OR, to pursue the neuromodulation market. Prospera incorporates a novel stimulation …

“BIOTRONIK pioneered the ability to monitor patients remotely in cardiac rhythm management, enabling early detection and treatment of critical events. With the introduction of a truly …

2023年4月19日 · Biotronik announced today that it received FDA approval for its Prospera spinal cord stimulation (SCS) system. The regulatory nod marks the launch of the Lake Oswego, …

2023年4月19日 · FDA Approval for BIOTRONIK’s Prospera™ Spinal Cord Stimulation System Global Leader in Cardiac Rhythm Technology Solutions Expands Therapies for the Treatment …